Remove 2003 Remove Chemotherapy Remove Hospitals
article thumbnail

Pharmacies Need Strategies to Improve Health Care Access

Pharmacy Times

Impact of a combined pharmacist and social worker program to reduce hospital readmissions. J Am Pharm Assoc (2003). Pharmacy’s Appointment Based Model: medication synchronization align my refills. APhA Foundation. Accessed May 5, 2025. Gil M, Mikaitis DK, Shier G, Johnson TJ, Sims S. J Manag Care Pharm. 2013;19(7):558-563.

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

From 2003 to 2023, 943 drugs were approved through the 505(b)(2) pathway. The hospitals and the payment plans would not use your generic drug if you weren’t therapeutically equivalent—we would exclude you,” Soefje said. As of January 1, 2023, CMS has begun issuing unique J-codes to 505(b)(2) drugs dating back to 2003. “In

FDA 65
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Meet the Expert: Myocarditis

Hospital Pharmacy Europe

Sanjay Prasad MD has been a consultant in cardiology and cardiovascular magnetic resonance at the Royal Brompton Hospital since 2003 and is also Professor of Cardiomyopathy at Imperial College, London. In contrast, in drug-related causes, especially chemotherapy, patients were generally aged 50–60 years. Reference Lota As et al.

article thumbnail

The evolution of durvalumab in NSCLC care

Hospital Pharmacy Europe

Durvalumab is ‘promising step forward’ The latest approval from the MHRA is based on positive data from the AEGEAN Phase III trial in rNSCLC , which showed that durvalumab-based treatment before and after surgery reduced the risk of recurrence, progression events or death by 32% versus neoadjuvant chemotherapy alone.

article thumbnail

What causes sharp pain on the right side of the body?

The Checkup by Singlecare

According to the CDC , treatment includes surgery, chemotherapy, radiation therapy, targeted therapy, or a combination of these treatments.